NATRELLE 133S TISSUE EXPANDERS 600 CC WITH SUTURE TABS 133S-MX-14-T

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-03-30 for NATRELLE 133S TISSUE EXPANDERS 600 CC WITH SUTURE TABS 133S-MX-14-T manufactured by Allergan, Inc..

Event Text Entries

[185521256] Pt. Undergoing breast reconstruction post mastectomy. While placing natrelle allergan tissue expander into right breast area, surgeon and cst noted an area of the device appeared to be not consistent with the rest of the implant. The item was discarded and a new device was implanted.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9896870
MDR Report Key9896870
Date Received2020-03-30
Date of Report2020-03-20
Date of Event2020-03-18
Report Date2020-03-20
Date Reported to FDA2020-03-20
Date Reported to Mfgr2020-03-30
Date Added to Maude2020-03-30
Event Key0
Report Source CodeUser Facility report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNATRELLE 133S TISSUE EXPANDERS 600 CC WITH SUTURE TABS
Generic NameEXPANDER, SKIN, INFLATABLE
Product CodeLCJ
Date Received2020-03-30
Model Number133S-MX-14-T
Catalog Number133S-MX-14-T
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Age0 YR
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerALLERGAN, INC.
Manufacturer Address301 W HOWARD LANE SUITE 100 AUSTIN TX 78753 US 78753


Patients

Patient NumberTreatmentOutcomeDate
10 2020-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.